Δ9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons

Journal of Molecular Neuroscience

Volumn 8, Issue 2, 1997, Pages 83-91

  Hernández, Maria L ^a   García Gil, Lucía ^a   Berrendero, Fernando ^a   Ramos, Jose A ^a   Fernández Ruiz, J Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Brain development; Cannabinoid receptors; Fetal mesencephalic neurons; Marijuana; Tyrosine hydroxylase; Tyrosine hydroxylase containing neurons; 9 tetrahydrocannabinol

Indexed keywords

CANNABINOID RECEPTOR; DRUG RECEPTOR; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RIMONABANT; TETRAHYDROCANNABINOL; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYMOLOGY; FEMALE; FETUS; MALE; MESENCEPHALON; METABOLISM; NERVE CELL; PREGNANCY; RAT; WISTAR RAT;

ANIMALS; CELLS, CULTURED; FEMALE; FETUS; MALE; MESENCEPHALON; NEURONS; PIPERIDINES; PREGNANCY; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL; TYROSINE 3-MONOOXYGENASE;

EID: 0031110055     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02736775     Document Type: Article

References (31)

1. Bading H., Ginty D. D., and Greenberg M. E. (1993) Regulation of gene expression in hippocampal sections by distinct calcium signalling pathways. Science 260, 181-186.
2. Belue R. C., Howlett A. L., Westlake T. M., and Hutchings D. E. (1995) The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 7, 25-30.
3. Bonnin A., de Miguel R., Rodrigüez-Mannzaneque J. C., Fernández-Ruiz J. J., Santos A., and Ramos J. A. (1994) Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Dev. Brain Res. 81, 147-150.
4. 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 56, 2177-2184.
5. 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. Mol. Neurosci. 7, 291-308.
6. Bouaboula M., Bourrié B., Rinaldi-Carmona M., Shire D., Le Fur G., and Casellas P. (1995a) Stimulation of cannabinoid receptor CB 1 induces kros-24 expression in human astrocytoma cells. J. Biol. Chem. 270, 13, 973-13, 980.
7. 1. Biochem. J. 312, 637-641.
8. Chiodo L. A. and Kapatos G. (1987) Mesencephalic neurons in primary culture: immunohistochemistry and membrane physiology, in Neurophysiology of Dopaminergic Systems - Current Status and Clinical Perspectives (Chiodo L. A. and Freeman A. S., eds.), Lakeshore, Grosse Pointe, MI, pp. 67-91.
9. Choi H. K., Won L., and Heller A. (1993) Dopaminergic neurons grown in three-dimensional reaggregate culture for periods of up to one year. J. Neurosci. Methods 46, 233-244.
10. Dunnet S. B. and Björklund A. (1991) Staging and dissection of rat embryos, in Neural Transplantation: A Practical Approach (Rickwood D. and Hammes B. D., eds.), Oxford University Press, Oxford, pp. 1-19.
11. Fernández-Ruiz J. J., Rodríguez de Fonseca F., Navarro M., and Ramos J. A. (1992) Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopaminergic neurons, in Marihuana/Cannabinoids: Neurobiology and Neurophysiology (Murphy L. L. and Bartke A., eds.), CRC, Boca Raton, FL, pp. 119-164.
12. Fernández-Ruiz J. J., Bonnin A., Cebeira M., and Ramos J. A. (1994) Ontogenic and adult changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure, in Strategies for Studying Brain Disorders, vol. I (Palomo T. and Archer T., eds.), Farrand, London, UK, pp. 357-390.
13. Fernández-Ruiz J. J., Romero J., García L., García-Palomero E., and Ramos J. A. (1996) Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana: developmental and adult studies, in Strategies for Studying Brain Disorders: Dopamine Disease States, vol. 3 (Beninger R. J., Palomo T., and Archer T., eds.), CYM, Madrid, Spain, pp. 359-387.
14. 40. Neurochem. Res. 18, 15-26.
15. Hewlett A. L. (1985) Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27, 429-436.
16. Howlett A. L. (1995) Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol. 35, 607-634.
17. Insel T. R. (1995) The development of the brain and behavior, in Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds.), Raven, New York, pp. 683-694.
18. Kedzierski W., Aguila-Mansilla N., Kozlowski G. P., and Porter J. C. (1994) Expression of tyrosine hydroxylase gene in cultured hypothalamic cells: roles of protein kinase A and C. J. Neurochem. 62, 431-437.
19. McLaughlin C. R. and Abood M. E. (1993) Developmental expression of cannabinoid receptor mRNA Dev. Brain Res. 76, 75-78.
20. McLaughlin C. R., Martin B. R., Compton D. R., and Abood M. E. (1994) Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol. Depend. 36, 27-31.
21. Mena M. A., Pardo B., Paino C. L., and Garcia de Yébenes J. (1993) Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid. Neuroreport 4, 438-440.
22. Nagatsu T., Oka K., and Kato T. (1979) Highly sensitive assay for tyrosine hydroxylase activity by high performance liquid chromatography. J. Chromat. 163, 247-252.
23. Navarro M., Rodríguez de Fonseca F., Hernández M. L., Ramos J. A., and Fernández-Ruiz J. J. (1994) Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 47, 47-58.
24. Navarro M., de Miguel R., Rodriguez de Fonseca F., Ramos J. A., and Fernández-Ruiz J. J. (1996) Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity in adult male rats. Behav. Brain Res. 75, 91-98.
25. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martínez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J. C., and Le Fur G. (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
26. 1 cannabinoid receptor isoforms. J. Pharmacol. Exp. Ther. 278, 871-878.
27. Rodríguez de Fonseca F., Cebeira M., Fernández-Ruiz J. J., Navarro M., and Ramos J. A. (1991) Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 43, 713-723.
28. Rodríguez de Fonseca F., Ramos J. A., Bonnin A., and Fernández-Ruiz J. J. (1993) Presence of cannabinoid binding sites the brain from early postnatal ages. Neuroreport 4, 135-138.
29. Walters D. E. and Carr L. A. (1986) Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol. Biochem. Behav. 25, 763-768.
30. Wessel T. C. and Joh T. C. (1992) Parallel upregulation of catecholamine-synthesizing enzymes in rat brain and adrenal gland: effects of reserpine and correlation with immediate early gene expression. Mol. Brain Res. 15, 349-360.
31. Zigmond R. E., Schwarzschild M. A., and Rittenhouse A. R. (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Ann. Rev. Neurosci. 12, 415-461.